ROS-scavenging nanozymes for anti-inflammation therapeutics

March 5, 2018, Nanjing University

The dysregulation of reactive oxygen species (ROS) is linked to inflammatory diseases including rheumatoid arthritis, cardiovascular disease and cancer. Live organisms have therefore evolved a number of highly efficient anti-inflammation enzymes with ROS-scavenging capabilities to protect tissues from inflammation-induced damage. However, the natural ROS-scavenging enzymes are sensitive to environmental conditions and are hard to mass produce. To address these challenges, numerous artificial enzymes with ROS-scavenging capabilities have been developed. Among them, ROS-scavenging nanozymes have recently attracted great interest owing to their enhanced stability, multi-functionality and tunable activity.

Nanozymes are catalytic nanomaterials with -mimicking activities. Several nanomaterials have been explored to develop ROS-scavenging nanozymes. For example, ceria nanoparticles (CeO2 NPs) have been demonstrated to possess superoxide dismutase (SOD)-mimicking activities due to the mixed valance states of Ce3+ and Ce4+. Biological studies have revealed that natural Mn SOD is superior to Cu/Zn SOD and Fe SOD, which implies that Mn-based nanozymes may have enhanced ROS-scavenging activities compared with known examples. Despite great promise, only a few Mn-based nanozymes have been reported. Moreover, they have not been used for in vivo anti-inflammation yet.

To tackle these challenges, Professor Wei at Nanjing University and his co-workers have now fabricated Mn3O4 NPs with multiple enzyme mimicking activities. The Mn3O4 nanozymes possessed SOD- and catalase-like activities as well as hydroxyl radical scavenging . Therefore, they scavenged the superoxide radical as well as hydrogen peroxide and the hydroxyl radical. Wei et al. also demonstrated that the Mn3O4 nanozymes were superior to CeO2 nanozymes in term of the ROS-scavenging activities. Moreover, they showed that the Mn3O4 nanozymes not only exhibited excellent ROS removal efficacy in vitro, but also effectively protected live mice from ROS-induced ear inflammation in vivo.

Their studies provided not only a highly efficient ROS-scavenging nanozyme, but also a promising therapeutic strategy for treating inflammation-related diseases.

Explore further: Integrated nanozymes for brain chemistry

More information: 10.1039/c7sc05476a Jia Yao et al. ROS scavenging Mn3O4 nanozymes for in vivo anti-inflammation, Chemical Science (2018). DOI: 10.1039/C7SC05476A

Related Stories

Integrated nanozymes for brain chemistry

April 13, 2016
Nanozymes are novel nanomaterials with enzyme mimicking activities, which are superior to natural enzymes and even conventional artificial enzymes. They have attracted considerable attention because they offer the possibility ...

Recommended for you

Mumps resurgence likely due to waning vaccine-derived immunity

March 21, 2018
A resurgence of mumps in the U.S. among vaccinated young adults appears to be due to waning of vaccine-induced immunity, according to a new analysis from Harvard T.H. Chan School of Public Health. Researchers found that vaccine-derived ...

Western diet depletes artery-protecting immune cells

March 21, 2018
New research from scientists at the La Jolla Institute For Allergy and Immunology shows how a diet high in fat and cholesterol depletes the ranks of artery-protecting immune cells, turning them into promoters of inflammation, ...

Quintupling inhaler medication may not prevent asthma attacks in children

March 19, 2018
Children with mild to moderate asthma do not benefit from a common practice of increasing their inhaled steroids at the first signs of an asthma exacerbation, according to clinical trial results published in The New England ...

How allergens trigger asthma attacks

March 19, 2018
A team of Inserm and CNRS researchers from the Institute of Pharmacology and Structural Biology have identified a protein that acts like a sensor detecting allergens in the respiratory tract that are responsible for asthma ...

Single steroid-bronchodilator treatment for control and rescue improves persistent asthma

March 19, 2018
When it comes to treating teens and adults with persistent asthma, using a single corticosteroid and long-acting bronchodilator treatment for both daily asthma control and for rescue relief during sudden asthma attacks is ...

Obesity and health problems: New research on a safeguard mechanism

March 16, 2018
Obesity and its negative impacts on health - including metabolic syndrome, type-2 diabetes mellitus and cardiovascular complications - are a global pandemic (Taubes, 2009). The worldwide incidence of obesity has more than ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.